Timur I. Fetisov

Timur I. Fetisov

Auto-generated profile, based on publicly available information

Timur I. Fetisov

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
TFT. I. Fetisov
T. I. Fetisov
ELEkaterina Lesovaya
Ekaterina Lesovaya
MYMarianna G Yakubovskaya
Marianna G Yakubovskaya
KKKirill Kirsanov
Kirill Kirsanov
GBGennady A. Belitsky
Gennady A. Belitsky
The WNT/β–catenin signaling pathway plays an important role in the differentiation and proliferation of hematopoietic cells. In recent years, special attention has been paid to the role of...

15 December 2019 in Advances in molecular oncology
Verified
Journal Article
Open access
PDF file
KKK. A. Kuzin
K. A. Kuzin
TFT. I. Fetisov
T. I. Fetisov
RKR. I. Knyazev
R. I. Knyazev
LFL. Ya. Fomina
L. Ya. Fomina
LML. V. Meheda
L. V. Meheda
KKKirill Kirsanov
Kirill Kirsanov
Objectives: to provide a rationale for existing approaches for the evaluation of chemoresistance of ovarian cancer in vitro, to perform a comparative analysis of the methods and to assess the perspectives of their further application.Materials and methods. For the review preparation, we analyzed articles on experimental testing of ovarian cancer resistance to chemotherapeutic agents, available at biomedical literature databases SciVerse Scopus (158), PubMed (323), Web of Science (285), RSCI (64). The review cited 37 recent publications, 12 of them being published over the past three years, and 16 articles being referred as pioneer publications on techniques previously and used today.Results. Peculiarities of the main methods for assessing the resistance and sensitivity of a cancer to various chemotherapeutic drugs using primary cultures of tumor cells obtained from biopsy or surgical material are analyzed. Proliferative and metabolic activities as well as the level of cell death were considered as the main evaluated characteristics of tumor cells. The methodological features of the described methods are discussed, as well as the prospects for their further application.Conclusion. Predictive detection of chemoresistance of ovarian cancer is based on testing the viability of tumor cells in the presence of a chemotherapeutic drug. The results of studies of the key mechanisms of chemoresistance development in tumor cells provide the rationale for improving in vitro testing.

15 December 2024 in RUDN Journal of Medicine
Verified
Journal Article
Open access
PDF file
AKAnna Kosyreva
Anna Kosyreva
ЭДЭнар Джуманиязова
Энар Джуманиязова
DDDzhuliia Dzhalilova
Dzhuliia Dzhalilova
ASAlexandra Vladislavovna Sentyabreva
Alexandra Vladislavovna Sentyabreva
EMEkaterina Miroshnichenko
Ekaterina Miroshnichenko
ЛВЛохонина А. В.
Лохонина А. В.
Relevance. Undifferentiated pleomorphic sarcoma (UPS) is one of the most common subtypes of soft tissue sarcomas. The polymorphism of tumor cells and high degree of malignancy account for the aggressive potential of UPS. Due to the rarity of occurrence and high heterogeneity of UPS, the number of studies describing the cellular composition and molecular-­biological characteristics is very limited. Objective is to assess the cellular composition and gene expression of UPS. Materials and Methods. Biomaterial from 10 patients with UPS was analyzed in the study. In this study we used primary antibodies to CD163 (marker of M2 macrophages) and Fibroblast activation protein (FAP — marker of fibroblasts) and secondary Caprine-­Anti-­Rabbit IgG HRP were used. HRP-tagged secondary antibodies were manifested using DAB. Antibodies for automated BOND-III IHC stainer were used to evaluate the microenvironment: CD68‑marker of macrophages, CD19‑marker of B-lymphocytes, CD56‑marker of neuroendocrine tumors, metastasis protein, Ki67 antigen-­proliferation marker, Bcl‑2‑oncoprotein. Staining on an automated BOND-III IHC stainer was performed according to standard protocols. In homogenized samples of tumor tissue and peritumoral area with the number of cells 106/ml in order to assess the microenvironment of the tumor and surrounding tissue, cytofluorimetric study of the relative number of CD14+ and CD16+ monocytes, CD68+ macrophages, CD86+ M1 macrophages, CD163+ and CD206+ M2 macrophages, CD4+ helper T-lymphocytes and CD45+ leukocytes was performed on the MACS Quant Analyzer device. The mRNA expression levels of HIF1A, VEGF, MMP2, ARG1, NOS2, and EGFR were determined in tumor tissue and peritumoral samples by PCR. The RNA Solo RNA kit was used for RNA isolation, and the MMLV RT Kit was used for reverse transcription. The amplification reaction with real-time detection was performed on aDTprime Real-­Time Amplifier. Results and Discussion. The expression of CD56, FAP, CD68 is characteristic for UPS. Among the cells of the microenvironment, macrophages and CD16‑monocytes predominate in UPS. EGFR expression level is increased in tumor cells of the UPS compared to the peritumoral region. The expression levels of ARG1, NOS2, HIF1A, VEGF, and MMP2 in tumors have individual differences and are not specific to the UPS. Conclusion. In our study, we analyzed the cellular composition and gene expression in UPS samples. Further follow-up of patients is necessary to evaluate the clinical significance of each marker.

9 December 2024 in Advances in molecular oncology
Verified
Journal Article
Open access
PDF file
MYMarianna G Yakubovskaya
Marianna G Yakubovskaya
TFT. I. Fetisov
T. I. Fetisov
LSL. G. Solenova
L. G. Solenova
NRN. I. Ryzhova
N. I. Ryzhova
ALA. V. Lokhonina
A. V. Lokhonina
VAV. V. Aginova
V. V. Aginova
Recent development of molecular and genetic technologies has demonstrated at the molecular level the co-evolutionary principles of interaction between microbiota, virome and the host organism, as well as the role of microorganisms and viruses both in maintaining physiological homeostasis and in the development of various diseases, including malignant neoplasms. The presented review is devoted to the analysis and generalization of modern data on microorganisms and viruses inhabiting the human body, their role in the processes of initiation, promotion and progression of carcinogenesis. The review provides information on known oncogenic viruses and microorganisms according to the modern classification of carcinogenic agents of the International Agency for Research on Cancer. Mechanistic data on the procarcinogenic effect of microbiota and virome are considered in accordance with the modern concept of key characteristics of a carcinogenic agent. Particular attention is paid to the analysis of data on the influence of microbiota and virome on the immunity of the host organism, including both the first results of immunotherapy with Coley toxin of soft tissue sarcomas and osteosarcomas, and data on the influence of individual types of microorganisms on the formation of the immunocompetent cell profile of the host organism. In addition, the influence of intratumor and intracellular microbiota, respectively, on the microenvironment of tumor cells and cellular signaling, including in solid tumors that have no contact with the external environment are also discussed. The data presented are important in terms of the holobiota concept, showing the interdependent existence of the human body, microorganisms and viruses, to improve the prevention and therapy of malignant neoplasms.

14 October 2025 in Bone and soft tissue sarcomas, tumors of the skin
Verified
Journal Article
Open access
PDF file
MSM. A. Senchenko
M. A. Senchenko
ATAnastasia Tararykova
Anastasia Tararykova
NKN. A. Kozlov
N. A. Kozlov
TFT. I. Fetisov
T. I. Fetisov
KKKirill Kirsanov
Kirill Kirsanov
DRD. V. Rogozhin
D. V. Rogozhin
Synovial sarcoma is characterized by a typical transcript SS18::SSX. However, despite a common pathogenesis and similar therapeutic approaches, opposite responses to therapy are sometimes observed. Supposedly, this can be associated with additional and alternative pathways of genetic and epigenetic regulation. In this review, the problems of synovial sarcoma diagnosis, pathogenesis and new therapy methods, including targeting epigenetics, are discussed.

30 April 2026 in Russian Journal of Biotherapy
Verified
Journal Article
Open access
PDF file
PSPolina A. Shtompel
Polina A. Shtompel
SKSofya A. Khazanova
Sofya A. Khazanova
ETEkaterina S. Trapeznikova
Ekaterina S. Trapeznikova
VZVictoria Yu. Zinovieva
Victoria Yu. Zinovieva
ALAnastasia A. Lovenger
Anastasia A. Lovenger
БЮБохян Б. Ю.
Бохян Б. Ю.
Background. Due to the limited number of cell lines, as well as the high heterogeneity of undifferentiated pleomorphic sarcomas (UPS), the creation of new stable cell lines is relevant. Aim. Obtaining a stable cell line from a sample of UPS obtained during surgery to model carcinogenesis processes in vitro and in vivo. Materials and methods. Cells were isolated from a tumor sample from a patient diagnosed with UPS. After passage 40 and stable growth, the proliferation rate, cell morphology, and growth ability in 3D culture conditions were assessed. To assess tumorigenicity, the cell suspension was injected into BALB / c nu / nu athymic mice. On the 15th day of the experiment, the tumor was removed, its volume was measured, and it was examined histologically. Using short tandem repeat (STR) analysis, the cells of the resulting line were examined for the presence of human cell markers and their uniqueness. The chemosensitivity of the cells was assessed using the resazurin test. Results. Stable growth and formation of spheroids under 3D culturing conditions were demonstrated for the cell culture. All mice inoculated with the UPS134 cell suspension showed tumor growth, and by day 14 of the experiment its average size was 28,7 mm3. Histologically, the tumor is similar in morphology to UPS, except for a smaller amount of myxoid and less polymorphism. The cells of the obtained line were shown to contain all analyzed genetic markers of human cells, and also that the STR data of the obtained line did not coincide with the STR of other lines. For doxorubicin, gemcitabine and docetaxel, IC50 (inhibitory concentration) were determined to be 15, 6.5 and 10 % of the plasma peak concentration, respectively. Conclusions. We obtained a new cell line UPS134, which can be further used to study the pathogenesis of UPS, as well as in preclinical studies of new antitumor agents in vitro and in vivo.